Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Psychedelics, psychiatry and pharmacokinetics - where are we now?

Expert Opin Drug Metab Toxicol August 19, 2025 DOI: 10.1080/17425255.2025.2549987 (opens in new tab) via PubMed

Summary

AI-generated from the abstract

Classical psychedelics are being explored as potential treatments for depression, anxiety, and addictions, differing from traditional psychiatric medications by their unique mechanisms of action. The text introduces their therapeutic promise but does not present a specific finding or result.

Study at a glance

Characteristics Peer reviewed

Abstract

1. Classical psychedelics are gaining attention as potential treatments for a range of neuropsychiatric conditions, including depression, anxiety, and addictions [1]. Psychedelics differ from tradi...

Comments

No comments yet.

Log in to comment